1. Session 30 Transition to the Certification Phase of Training
150 Minutes
Session 30
Transition to the Certification Phase of Training
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

2. Learning Objectives
Demonstrate mastery of the knowledge and skills the course was intended to help develop
Summarize the key topics covered
Offer comments and suggestions for improving the course
Receive assignments for Field Certification Training
Understand the steps in the DRE certification process
Briefly review the objectives, content and activities of this session.
Upon successfully completing this session the participant will be able to:
Demonstrate their mastery of the knowledge and skills the course was intended to help develop.
Summarize the key topics covered.
Offer comments and suggestions for improving the course.
Receive assignments for Field Certification Training.
Understand the steps involved in the DRE certification process.
CONTENT SEGMENTS LEARNING ACTIVITIES
A. Summary Participant-Led Presentations
B. Post Test Participants’ Anonymous Critique of Course
C. Session Wrap-Up Knowledge Examination
D. Certification Process, Training Instructor-Led Presentation
Assignments and Schedule
E. Closing Remarks
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

3. The Seven Categories of Drugs
CNS Depressants
CNS Stimulants
Hallucinogens
Dissociative Anesthetics
Narcotic Analgesics
Inhalants
Cannabis
Summary
The Seven Categories of Drugs
Ask participants to name the seven categories.
Make sure all categories are named, then reveal the bottom of the slide with the list.
CNS Depressants
CNS Stimulants
Hallucinogens
Dissociative Anesthetics
Narcotic Analgesics
Inhalants
Cannabis
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

4. Drug Evaluation and Classification Procedure
What are the components of the procedure?
Breath Alcohol Test
Interview of Arresting Officer
Preliminary Examination
Examinations of Eyes
Divided Attention Tests
The Drug Evaluation and Classification Procedure
Ask participants to name the components of the procedure. Make sure all components are named, then reveal the bottom portion of the slide with the components listed.
Breath Alcohol Test
Interview of Arresting Officer
Preliminary Examination
Examinations of Eyes
Divided Attention Tests
Ask participants to discuss the kinds of evidence/ information gleaned from each component.
30-4
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

5. Drug Evaluation and Classification Procedure
What are the components of the procedure?
Vital Signs Examinations
Check for Muscle Tone
Inspection for Injection Sites
Statements and Observations
Opinion of the Evaluator
Toxicological Examination
The Drug Evaluation and Classification Procedure
Ask participants to name the components of the procedure. Make sure all components are named, then reveal the bottom portion of the slide with the components listed.
Vital Signs Examinations
Check for Muscle Tone
Inspection for Injection Sites
Statements and Observations
Opinion of the Evaluator
Toxicological Examination
Ask participants to discuss the kinds of evidence/ information gleaned from each component.
30-5
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

6. Major Signs and Symptoms
CNS Depressants
CNS Stimulants
Hallucinogens
Dissociative Anesthetics
Narcotic Analgesics
Inhalants
Cannabis
Major Signs and Symptoms
Instruct participants to turn to the symptomatology chart in their manuals.
Briefly summarize and review the major signs and symptoms associated with each drug category. Reveal each category one at a time and conduct the review.
Solicit participants’ questions concerning the major content topics of the course.
Inform the participants that the final exam in a “closed book” test. Instruct them to put all books and notes away.
30-6
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

7. Knowledge Examination
Post-Test
Knowledge Examination
Distribute post-test knowledge examinations.
Allow students approximately 80 minutes to complete the knowledge examination.
Collect the completed knowledge examination.
Grade the knowledge exams
Post-Test
30-7
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

8. Critique Critique Form Session Wrap-Up Critique
Hand-out critique forms to the participants for completion.
30-8
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

9. The Three-Phases of Training for the DEC Program
Certification involves three-phase training process:
Phase I- Two-day (16-hour) Pre-school
Phase II- Seven-day (56-hour) DRE School
Phase III- Field Certifications (usually within 60 to 90 days, but not longer than six months following the completion of the classroom training)
Certification Training Assignments and Schedule
Remind the participants of the three phases of training needed to complete their certification process:
Phase I - Pre-School
Phase II - DRE School
Phase III - Field Certifications
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

10. Field Evaluations Requirements
12 evaluations (minimum)
9 toxicology samples collected
7 positive (confirmed) toxicology samples from the lab
6 of the 12 evaluations conducted - YOU must be the evaluator
3 of the 7 drug categories must be encountered
Evaluations must be witnessed and supervised by a DRE Instructor
Review with the participants the IACP International Standards for DRE certification.
IACP Standard 1.10 requires that the candidate DRE satisfactorily complete a minimum of twelve (12) evaluations, identifying subjects under the influence of at least three of the drug categories. All three must be supported by toxicology.
The candidate DRE must also act as the evaluator for at least six evaluations.
All evaluations, either administered or observed must be documented on the candidate’s rolling log.
Candidate DREs need to have toxicology samples from at least nine (9) subjects evaluated during the certification process.
The candidate DRE cannot be certified unless the opinion concerning the drug category(s) is supported by toxicology 75 percent of the time or in at least seven (7) of the nine samples submitted for certification.
Field certification evaluations must be observed and supervised by a DRE instructor to count towards minimum certification requirements. The evaluation must be observed in its entirety and the instructor who observed the entire evaluation must sign-off on the observed evaluation
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

11. Field Certifications What’s needed for the Field Certification nights?
DRE kits
Certification Progress Log
Your Participant Manual
Your Rolling Log
A prepared mind
Field Certifications
Remind the participants of what will be needed for the field certifications.
Should include the following:
DRE kits
Certification Progress Log
DRE Participant Manual
Rolling Log
A “prepared mind”
Remind participants that DRE field certifications must be completed as soon as possible following completion of the classroom training.
Remind the participants that by the time they have completed field certification(s), they shall have prepared a Curriculum Vitae (C.V.).
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

12. The Final Certification Knowledge Examination
Standard 1.12…Prior to concluding field certification training, the candidate shall satisfactorily complete an approved “Certification Knowledge Examination”
…The examination shall only be administered after the candidate has completed not less than three drug evaluations
Standard 1.12…Prior to concluding field certification training, the candidate shall satisfactorily complete an approved “Certification Knowledge Examination”
…The examination shall only be administered after the candidate has completed not less than three drug evaluations
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

13. The Final Certification Knowledge Examination
A multi-part, comprehensive examination
No significant errors or omissions allowed
Examines candidate’s overall knowledge
Final Certification Knowledge Examination
Prior to concluding the certification process, the candidate DRE must satisfactorily complete an IACP approved Final Certification Knowledge Examination.
The Final Certification Knowledge Examination is a multi-part comprehensive examination where the participant can not make significant errors or omissions.
Examination consists of five parts which tests the candidate DRE’s knowledge of the drug symptomatology matrix, drug effects, drug combinations, and report writing skills.
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

14. IACP Certification Progress Log
After each component required for certification is completed, a DRE Instructor must sign off on your log
You must be recommended for certification by two DRE Instructors
Instructors will sign off in the Authorized Signature portion at the bottom of the Progress Log
After each component required for certification is completed, a DRE Instructor must sign off on the DRE candidate’s log.
The candidate DRE must be recommended for certification by two DRE instructors.
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

15. How Long Am I Certified For?
DRE Certification is good for two years
DRE’s shall be required to renew their certificate of continuing proficiency every two years
DRE Certification
DRE certification is for a period of two years.
DRE’s shall be required to renew their certificate of continuing proficiency every two years
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

16. How Do I Maintain Proficiency?
IACP International Standard 3.4…A DRE shall demonstrate continuing proficiency by:
Performing a minimum of four (4) acceptable evaluations since the date of last certification…
Completing a minimum of eight (8) hours of recertification training…
Presenting an updated Curriculum Vitae and Rolling Log to the appropriate coordinator for review and approval
Once certified, DREs shall be required to renew their certificates of continuing proficiency every two years.
Continuing proficiency requires:
Performing a minimum of four (4) acceptable drug evaluations since the last date of certification;
Completing a minimum of eight (8) hours of approved re-certification training; and
Presenting an updated C.V. and Rolling Log to the appropriate coordinator for review.
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

17. QUESTIONS?
Solicit questions from participants regarding the field certifications and certification process.
30-17
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training

18. Congratulations! Drug Recognition Expert Training
E. Closing Remarks
Closing remarks will be offered by appropriate representatives of the department of faculty.
You have successfully completed the
Drug Recognition Expert Training
conducted here
Revised:
Drug Recognition Expert Course
Transition to the Certification Phase of Training